Comparative study of Atibala Avaleha and Darvi Amalaki Avaleha in dysuria

Comparative study of the efficacy of Atibala Avaleha with Darvi Amalaki Avaleha in Pittaj Mutrakruchchrra

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008901

Enrollment

Registered

2017-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of Pittaj Mutrakruchchhra

Interventions

Intervention1: Atibala Avaleha: Atibala Avaleha 40ml twice a day orally will be given to the patients for 7 days Control Intervention1: Darvi Amalaki: Darvi Amalaki Avaleha 40ml twice a day orally wil

Eligibility

Inclusion criteria

Inclusion criteria: The patients having signs and symptoms of Pittaj Mutrakruchchhra i.e. sadaha, sashula, sarakta, sapeeta, muhurmuhu mutrapravrutti

Exclusion criteria

Exclusion criteria: 1) K/C/O HIV infection and Malignancy. 2) K/C/O Mutraghat, Ashmari(Renal, Vesicular Calculus), Bening Prostrate, Hypertrophy, Urethral Stricture, Phimosis, Tumors,Trauma to Urogenital Tract 3) Congenital cause and Obstructive Pathology. 4) Systemic diseases like Diabetes Mellitus, T.B. etc.

Design outcomes

Primary

Measure	Time frame
Comparative Study Of The Efficacy Of Atibala Avaleha In Pittaj Mutrakruchchhra and Compare with Darvi Amalaki AvalehaTimepoint: 10 Months	—

Secondary

Measure	Time frame
To study the changes in pH of Urine with Atibala AvalehaTimepoint: 10 months	—

Countries

India

Contacts

Public ContactDr Yogesh T Kotangale

MAM Sumatibhai Shah Ayurved College

devikapawar89@gmail.com9975817770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026